Exelixis Inc (EXEL) Stock Price, Quote, News & History

EXELNASDAQ
$52.44
0.340.65%
At close: Jun 17, 5:00 PM EST
$52.40
-0.04-0.08%
After Hours: 7:47 PM EST
40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
924.68M
Investing Cash Flow (TTM)
249.61M
Financing Cash Flow (TTM)
-1.13B
Free Cash Flow (TTM)
905.17M
Capital Expenditure (TTM)
-19.51M
Net Change in Cash (TTM)
42.40M

Analyst Trends and Forecast

2
1
Jan
2
3
Feb
0
0
0
0
Mar
1
Apr
2
2
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
2.5
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$12.49B
PE Ratio (TTM)
17.25
PE Ratio (FWD)
16.47
PEG Ratio (TTM)
-
PS Ratio (TTM)
6.07
PB Ratio (TTM)
6.77
Earnings Yield % (TTM)
5.80%
Earnings Yield % (FWD)
6.07%
EV / EBITDA (TTM)
12.67
Price / EBITDA (TTM)
14.62
Price / Free Cash Flow (TTM)
15.92
Book Value / Share
$7.70

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$226.15M
Debt to Equity
0.09
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$52.10
Close
$52.44
Volume / Avg.
2.02M / 2.53M
Day Range
$51.55 - $53.00
52 Wk Range
33.76 - 53.93
Market Cap
$13.31B
P/E Ratio
17.25
Dividend Yield
-
Exchange
NASDAQ
RSI
58
Short Interest
15.84%
Days to Cover
12.35

About

Sector
Health Care
Industry
Biotechnology
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and f...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Exelixis (EXEL) stock?

A

You can purchase shares of Exelixis (NASDAQ:EXEL) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Exelixis (EXEL) competitors?

A

There are no as such competitors for Exelixis.

Q

What is the forecast, or price target, for Exelixis (EXEL) stock?

A

Exelixis has a consensus price target of $45.75.

Q

What is the current price for Exelixis (EXEL)?

A

The stock price for Exelixis (NASDAQ: EXEL) is $52.4 last updated June 17, 2026 at 7:47 PM EDT.

Q

Does Exelixis (EXEL) pay a dividend?

A

There are no upcoming dividends for Exelixis.

Q

When is Exelixis (NASDAQ:EXEL) reporting earnings?

A

Exelixis does not have any upcoming earnings scheduled.

Q

Is Exelixis (EXEL) going to split?

A

There is no upcoming split for Exelixis.

Q

What sector and industry does Exelixis (EXEL) operate in?

A

Exelixis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.